Reducing the Hemorrhagic Complications of Hemodialysis: A Controlled Comparison of Low-Dose Heparin and Citrate Anticoagulation
- 1 February 1987
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 9 (2) , 147-153
- https://doi.org/10.1016/s0272-6386(87)80092-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Regional Anticoagulation: Hemodialysis With Hypertonic Trisodium CitrateAmerican Journal of Kidney Diseases, 1986
- Regional Citrate Anticoagulation for Hemodialysis in the Patient at High Risk for BleedingNew England Journal of Medicine, 1983
- Hemodialysis Using Prostacyclin Instead of Heparin as the Sole Antithrombotic AgentNew England Journal of Medicine, 1981
- Hemorrhage during High-Risk Hemodialysis Using Controlled HeparinizationNephron, 1981
- Preventing hemorrhage in high-risk hemodialysis: Regional versus low-dose heparinKidney International, 1979
- Spontaneous Retroperitoneal Bleeding in Patients on Chronic HemodialysisAnnals of Internal Medicine, 1977
- PRECISE CONTROL OF MINIMAL HEPARINIZATION FOR HIGH BLEEDING RISK HEMODIALYSISAsaio Journal, 1977
- Hemorrhagic Pleural Effusion in Patients Undergoing Chronic HemodialysisAnnals of Internal Medicine, 1975
- Anticoagulation Rebound after HemodialysisNew England Journal of Medicine, 1966
- Studies in Regional HeparinizationNew England Journal of Medicine, 1956